Near infrared risk assessment of diseases

A - Human Necessities – 61 – B

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61B 5/055 (2006.01)

Patent

CA 2481857

The present invention provides an apparatus and a method for identifying the risk of a clinical condition in a human or animal by correlating Near Infrared (NIR) absorbance spectral data with one or several parameters including a concentration of one or more substances in the skin, a concentration of one or more substances in skin plus subdermal tissue, a score derived from one or more clinical tests like a stress test on a treadmill, coronary angiography, or intravascular coronary ultrasound. The method determines the concentration of a compound in the skin of a human or animal and comprises the steps of placing a part of the skin against a receptor, directing electromagnetic radiation (EMR) from the near-infrared spectrum onto the skin, measuring a quantity of EMR reflected by, or transmitted through, the skin with a detector; and performing a quantitative mathematical analysis of the quantity of EMR to determine the concentration of the compound, for example free and esterfied cholesterol. An example of a clinical condition is cardiovascular disease.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Near infrared risk assessment of diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Near infrared risk assessment of diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Near infrared risk assessment of diseases will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1659381

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.